Saturday, October 30, 2021 4:39:14 PM
Our Lobbyist trying to get Bucillamine noticed at a Covid treatment Summit replying to Robert Malone.
https://twitter.com/danfaraci/status/1454495093470203917?t=u60KONO6X8DLuHnVZhAubQ&s=19
https://twitter.com/danfaraci/status/1454495093470203917?t=u60KONO6X8DLuHnVZhAubQ&s=19
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
